Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 3—March 2005
Research

Ebola Virus Antibody Prevalence in Dogs and Human Risk

Loïs Allela*, Olivier Bourry*, Régis Pouillot†, André Délicat*, Philippe Yaba*, Brice Kumulungui*, Pierre Rouquet*, Jean-Paul Gonzalez‡, and Eric M. Leroy*‡Comments to Author 
Author affiliations: *Centre International de Recherches Médicales de Franceville, Franceville, Gabon; †Centre Pasteur du Cameroun, Yaoundé, Cameroun; ‡Institut de Recherche pour le Développement, Paris, France

Main Article

Figure 1

Locations of the main towns of Gabon (Libreville and Port Gentil) and the villages in the Ebola virus–epidemic area during the 2001–2002 outbreak in Gabon. The villages where human cases of Ebola infection were observed are indicated by “H.” The villages where both human patients and infected animal carcass were observed are indicated by “H/A.”

Figure 1. . . Locations of the main towns of Gabon (Libreville and Port Gentil) and the villages in the Ebola virus–epidemic area during the 2001–2002 outbreak in Gabon. The villages where human cases of Ebola infection were observed are indicated by “H.” The villages where both human patients and infected animal carcass were observed are indicated by “H/A.”

Main Article

¹Loïs Allela and Olivier Bourry contributed equally to this work.

Page created: April 25, 2012
Page updated: April 25, 2012
Page reviewed: April 25, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external